Cowen raises $1 bn royalty fund
This article was originally published in Scrip
Executive Summary
Cowen Healthcare Royalty Partners has closed its second fund at nearly $1 billion, exceeding its $550 million target by more than 75%. Cowen Healthcare Royalty Partners II LP (CHRP II) will have a similar profile to the first fund, focusing on commercial stage biopharmaceutical and medical device companies in need of growth capital and universities and inventors looking to monetise product interests.